107 related articles for article (PubMed ID: 28977945)
1. Genetic polymorphisms of long non-coding RNA GAS5 predict platinum-based concurrent chemoradiotherapy response in nasopharyngeal carcinoma patients.
Guo Z; Wang Y; Zhao Y; Jin Y; An L; Wu B; Liu Z; Chen X; Zhou H; Wang H; Zhang W
Oncotarget; 2017 Sep; 8(37):62286-62297. PubMed ID: 28977945
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic role of lncRNA GAS5 and its genetic polymorphisms rs2067079, rs6790 and rs17359906 in rheumatoid arthritis.
Elamir AM; Senara S; Abdelghaffar NK; Gaber SN; El Sayed HS
Biomed Rep; 2021 Nov; 15(5):93. PubMed ID: 34631048
[TBL] [Abstract][Full Text] [Related]
3. Do circulating long non-coding RNAs (lncRNAs) (LincRNA-p21, GAS 5, HOTAIR) predict the treatment response in patients with head and neck cancer treated with chemoradiotherapy?
Fayda M; Isin M; Tambas M; Guveli M; Meral R; Altun M; Sahin D; Ozkan G; Sanli Y; Isin H; Ozgur E; Gezer U
Tumour Biol; 2016 Mar; 37(3):3969-78. PubMed ID: 26482616
[TBL] [Abstract][Full Text] [Related]
4. Linc00312 Single Nucleotide Polymorphism as Biomarker for Chemoradiotherapy Induced Hematotoxicity in Nasopharyngeal Carcinoma Patients.
Guo Z; Wang YJ; He BS; Zhou J
Dis Markers; 2022; 2022():6707821. PubMed ID: 35990252
[TBL] [Abstract][Full Text] [Related]
5. A Single Nucleotide Polymorphism in GAS5 lncRNA is Associated with Risk of Bladder Cancer in Iranian Population.
Rakhshan A; Esmaeili MH; Kahaei MS; Taheri M; Omrani MD; Noroozi R; Ghafouri-Fard S
Pathol Oncol Res; 2020 Apr; 26(2):1251-1254. PubMed ID: 31250374
[TBL] [Abstract][Full Text] [Related]
6. Genetic Polymorphisms of Long Non-coding RNA Linc00312 Are Associated With Susceptibility and Predict Poor Survival of Nasopharyngeal Carcinoma.
Guo Z; Bao MH; Fan YX; Zhang Y; Liu HY; Zhou XL; Wu B; Lu QQ; He BS; Nan XY; Lu JY
Front Cell Dev Biol; 2021; 9():698558. PubMed ID: 34336850
[TBL] [Abstract][Full Text] [Related]
7. GAS5 genomic variants and risk of multiple sclerosis.
Mahdi Eftekharian M; Noroozi R; Komaki A; Mazdeh M; Taheri M; Ghafouri-Fard S
Neurosci Lett; 2019 May; 701():54-57. PubMed ID: 30790644
[TBL] [Abstract][Full Text] [Related]
8. Effects of gene polymorphisms in the endoplasmic reticulum stress pathway on clinical outcomes of chemoradiotherapy in Chinese patients with nasopharyngeal carcinoma.
Guo XB; Ma WL; Liu LJ; Huang YL; Wang J; Huang LH; Peng XD; Yin JY; Li JG; Chen SJ; Yang GP; Wang H; Guo CX
Acta Pharmacol Sin; 2017 Apr; 38(4):571-580. PubMed ID: 28216622
[TBL] [Abstract][Full Text] [Related]
9. A Functional 5'-UTR Polymorphism of MYC Contributes to Nasopharyngeal Carcinoma Susceptibility and Chemoradiotherapy Induced Toxicities.
Guo Z; Wang Y; Zhao Y; Jin Y; An L; Xu H; Liu Z; Chen X; Zhou H; Wang H; Zhang W
J Cancer; 2019; 10(1):147-155. PubMed ID: 30662535
[TBL] [Abstract][Full Text] [Related]
10. Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
Zhang J; Chen S; Li G; Zhang W; Qin T; Yin P; Huang H; Jiang H
Cancer Chemother Pharmacol; 2017 Jun; 79(6):1087-1097. PubMed ID: 28429051
[TBL] [Abstract][Full Text] [Related]
11. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
[TBL] [Abstract][Full Text] [Related]
12. Genetic polymorphisms of lncRNA-p53 regulatory network genes are associated with concurrent chemoradiotherapy toxicities and efficacy in nasopharyngeal carcinoma patients.
Wang Y; Guo Z; Zhao Y; Jin Y; An L; Wu B; Liu Z; Chen X; Chen X; Zhou H; Wang H; Zhang W
Sci Rep; 2017 Aug; 7(1):8320. PubMed ID: 28814798
[TBL] [Abstract][Full Text] [Related]
13. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma : A matched-pair multicenter analysis of outcomes.
Dong YY; Xiang C; Lu JX; Su YX; Pan YF; Cai R; Zhang RJ; He ZK; Liu ML; Huang H; Bai X; Tang HY; Shi YH; Wang Y; Jiang W
Strahlenther Onkol; 2016 Jun; 192(6):394-402. PubMed ID: 27215563
[TBL] [Abstract][Full Text] [Related]
14. Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trial.
Chen QY; Wen YF; Guo L; Liu H; Huang PY; Mo HY; Li NW; Xiang YQ; Luo DH; Qiu F; Sun R; Deng MQ; Chen MY; Hua YJ; Guo X; Cao KJ; Hong MH; Qian CN; Mai HQ
J Natl Cancer Inst; 2011 Dec; 103(23):1761-70. PubMed ID: 22056739
[TBL] [Abstract][Full Text] [Related]
15. Identification of circulating long non-coding RNA GAS5 as a potential biomarker for non-small cell lung cancer diagnosisnon-small cell lung cancer, long non-coding RNA, plasma, GAS5, biomarker.
Tan Q; Zuo J; Qiu S; Yu Y; Zhou H; Li N; Wang H; Liang C; Yu M; Tu J
Int J Oncol; 2017 May; 50(5):1729-1738. PubMed ID: 28339045
[TBL] [Abstract][Full Text] [Related]
16. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
Cao S; Liu W; Li F; Zhao W; Qin C
Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
[TBL] [Abstract][Full Text] [Related]
17. LncRNA GAS5 rs145204276 Polymorphism Reduces Renal Cell Carcinoma Susceptibility in Southern Chinese Population.
Xiang X; Chen L; He J; Ma G; Li Y
J Inflamm Res; 2022; 15():1147-1158. PubMed ID: 35210817
[TBL] [Abstract][Full Text] [Related]
18. Association between indel polymorphism in the promoter region of lncRNA GAS5 and the risk of hepatocellular carcinoma.
Tao R; Hu S; Wang S; Zhou X; Zhang Q; Wang C; Zhao X; Zhou W; Zhang S; Li C; Zhao H; He Y; Zhu S; Xu J; Jiang Y; Li L; Gao Y
Carcinogenesis; 2015 Oct; 36(10):1136-43. PubMed ID: 26163879
[TBL] [Abstract][Full Text] [Related]
19. Concurrent chemoradiotherapy with nedaplatin plus paclitaxel or fluorouracil for locoregionally advanced nasopharyngeal carcinoma: Survival and toxicity.
Xu J; He X; Cheng K; Guo W; Bian X; Jiang X; Zhang L; Huang S
Head Neck; 2014 Oct; 36(10):1474-80. PubMed ID: 23996842
[TBL] [Abstract][Full Text] [Related]
20. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
